RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
86 hedge funds and large institutions have $235M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-3
Holders Change %
-3.37%
% of All Funds
1.97%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
11
Increased
32
Reduced
19
Closed
13
Calls
$383K
Puts
$262K
Net Calls
+$121K
Net Calls Change
-$137K
Top Buyers
Top Sellers
1 |
LCM
Laurion Capital Management
New York
|
-$7.32M |
2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$1.39M |
3 |
![]()
JPMorgan Chase & Co
New York
|
-$1.14M |
4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.12M |
5 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
-$1.09M |